Tower Research Capital LLC (Trc) Transcode Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.33 - $984.0 $279 - $832,464	846 Added 15.37%	6,351 $4,000
Q3 2022 Nov 10, 2022	SELL	$1.01 - $952.0 $517 - $487,424	-512 Reduced 8.51%	5,505 $6,000
Q2 2022 Aug 15, 2022	BUY	$1.2 - $3.03 $4,850 - $12,247	4,042 Added 204.66%	6,017 $8,000
Q1 2022 May 12, 2022	SELL	$2.03 - $3.01 $718 - $1,065	-354 Reduced 15.2%	1,975 $6,000
Q4 2021 Feb 14, 2022	BUY	$2.42 - $3.41 $2,071 - $2,918	856 Added 58.11%	2,329 $6,000
Q3 2021 Nov 15, 2021	BUY	$2.37 - $6.45 $3,491 - $9,500	1,473 New	1,473 $4,000

6.5K

Ticker RNAZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,977,200
Market Cap $45.7M
Description
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs incl...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.